The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States
Authors:
Open Access
- 16 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (11) , 1910-1919
Abstract
Background: Although norovirus outbreaks periodically make headlines, it is unclear how much attention norovirus may receive otherwise. A better understanding of the burden could help determine how to prioritize norovirus prevention and control. Methods: We developed a computational simulation model to quantify the clinical and economic burden of norovirus in the United States. Results: A symptomatic case generated $48 in direct medical costs, $416 in productivity losses ($464 total). The median yearly cost of outbreaks was $7.6 million (range across years, $7.5–$8.2 million) in direct medical costs, and $165.3 million ($161.1–$176.4 million) in productivity losses ($173.5 million total). Sporadic illnesses in the community (incidence, 10–150/1000 population) resulted in 14 118–211 705 hospitalizations, 8.2–122.9 million missed school/work days, $0.2–$2.3 billion in direct medical costs, and $1.4–$20.7 billion in productivity losses ($1.5–$23.1 billion total). The total cost was $10.6 billion based on the current incidence estimate (68.9/1000). Conclusion: Our study quantified norovirus’ burden. Of the total burden, sporadic cases constituted >90% (thus, annual burden may vary depending on incidence) and productivity losses represented 89%. More than half the economic burden is in adults ≥45, more than half occurs in winter months, and >90% of outbreak costs are due to person-to-person transmission, offering insights into where and when prevention/control efforts may yield returns.Keywords
Funding Information
- Vaxart, the Agency for Healthcare Research and Quality (R01HS023317)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Behavioral and Social Sciences Research and the Global Obesity Prevention Center (U54HD070725)
- United States Agency for International Development
This publication has 26 references indexed in Scilit:
- Norovirus Disease in the United StatesEmerging Infectious Diseases, 2013
- Incidence of Acute Gastroenteritis and Role of Norovirus, Georgia, USA, 2004-2005Emerging Infectious Diseases, 2011
- Increasing Rates of Gastroenteritis Hospital Discharges in US Adults and the Contribution of Norovirus, 1996–2007Clinical Infectious Diseases, 2011
- Community Incidence of Norovirus-associated Infectious Intestinal Disease in England: Improved Estimates Using Viral Load for Norovirus DiagnosisAmerican Journal of Epidemiology, 2010
- Editorial Commentary:Digital Decision Making: Computer Models and Antibiotic Prescribing in the Twenty‐First CenturyClinical Infectious Diseases, 2008
- Outbreak Management and Implications of a Nosocomial Norovirus OutbreakClinical Infectious Diseases, 2007
- Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United StatesPediatrics, 2007
- Impact of an Outbreak of Norovirus Infection on Hospital ResourcesInfection Control & Hospital Epidemiology, 2005
- Incidence and characteristics of endemic Norwalk‐like virus‐associated gastroenteritisJournal of Medical Virology, 2003
- Natural History of HumanCalicivirusInfection: A Prospective Cohort StudyClinical Infectious Diseases, 2002